<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pinheiro-Junior EL</submitter><funding>São Paulo Research Foundation</funding><funding>F.W.O.-Vlaanderen</funding><funding>Johann Wolfgang Goethe-Universität, Frankfurt am Main</funding><funding>LOEWE TBG</funding><funding>EU COST Action</funding><funding>KU Leuven funding</funding><pagination>164</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11288129</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The identification of novel toxins from overlooked and taxonomically exceptional species bears potential for various pharmacological applications. The remipede Xibalbanus tulumensis, an underwater cave-dwelling crustacean, is the only crustacean for which a venom system has been described. Its venom contains several xibalbin peptides that have an inhibitor cysteine knot (ICK) scaffold.&lt;h4>Results&lt;/h4>Our screenings revealed that all tested xibalbin variants particularly inhibit potassium channels. Xib&lt;sub>1&lt;/sub> and xib&lt;sub>13&lt;/sub> with their eight-cysteine domain similar to spider knottins also inhibit voltage-gated sodium channels. No activity was noted on calcium channels. Expanding the functional testing, we demonstrate that xib&lt;sub>1&lt;/sub> and xib&lt;sub>13&lt;/sub> inc</pubmed_abstract><journal>BMC biology</journal><pubmed_title>Diversely evolved xibalbin variants from remipede venom inhibit potassium channels and activate PKA-II and Erk1/2 signaling.</pubmed_title><pmcid>PMC11288129</pmcid><funding_grant_id>G0E7120N</funding_grant_id><funding_grant_id>GOC2319 N</funding_grant_id><funding_grant_id>CA19144 EUVEN</funding_grant_id><funding_grant_id>GOA4919 N</funding_grant_id><funding_grant_id>2016/04761-4</funding_grant_id><funding_grant_id>PDM/19/164</funding_grant_id><pubmed_authors>Furst R</pubmed_authors><pubmed_authors>Hempel BF</pubmed_authors><pubmed_authors>Koludarov I</pubmed_authors><pubmed_authors>Erkoc P</pubmed_authors><pubmed_authors>Peigneur S</pubmed_authors><pubmed_authors>Isensee J</pubmed_authors><pubmed_authors>Tytgat J</pubmed_authors><pubmed_authors>von Reumont BM</pubmed_authors><pubmed_authors>Schiffmann S</pubmed_authors><pubmed_authors>Sennoner T</pubmed_authors><pubmed_authors>Hucho T</pubmed_authors><pubmed_authors>Alirahimi E</pubmed_authors><pubmed_authors>Pinheiro-Junior EL</pubmed_authors><pubmed_authors>Vilcinskas A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diversely evolved xibalbin variants from remipede venom inhibit potassium channels and activate PKA-II and Erk1/2 signaling.</name><description>&lt;h4>Background&lt;/h4>The identification of novel toxins from overlooked and taxonomically exceptional species bears potential for various pharmacological applications. The remipede Xibalbanus tulumensis, an underwater cave-dwelling crustacean, is the only crustacean for which a venom system has been described. Its venom contains several xibalbin peptides that have an inhibitor cysteine knot (ICK) scaffold.&lt;h4>Results&lt;/h4>Our screenings revealed that all tested xibalbin variants particularly inhibit potassium channels. Xib&lt;sub>1&lt;/sub> and xib&lt;sub>13&lt;/sub> with their eight-cysteine domain similar to spider knottins also inhibit voltage-gated sodium channels. No activity was noted on calcium channels. Expanding the functional testing, we demonstrate that xib&lt;sub>1&lt;/sub> and xib&lt;sub>13&lt;/sub> inc</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-03T00:18:27.999Z</modification><creation>2026-04-22T03:11:59.952Z</creation></dates><accession>S-EPMC11288129</accession><cross_references><pubmed>39075558</pubmed><doi>10.1186/s12915-024-01955-5</doi></cross_references></HashMap>